Why Australian equities are set for a strong rally

Jun Bei Liu of Tribeca Investment Partners (Core and Conference Fund Manager) tells The Australian Financial Review why she believes Australian equities are set for a strong rally.

Jun Bei Liu

Why Australian equities are set for a strong rally

May 7, 2023
Jun Bei Liu of Tribeca Investment Partners (Core and Conference Fund Manager) tells The Australian Financial Review why she believes Australian equities are set for a strong rally.
Read Transcript

We came into 2023 with a positive, non-consensus view on Australian shares.

We maintain this view, and think the outlook is not as bad as forecast by many in the market; Australia is likely to avoid the deep downgrades that are now beginning to unfold elsewhere in the world, most notably in the US.

The ASX 200, along with other global sharemarket indices, has shown a healthy uptrend since the beginning of the year.
Corporate earnings are likely to stabilise in the second half. Louie Douvis

There will, of course, be some near-term weaknesses as tighter monetary policy eventually slows activity, and we expect earnings downgrade momentum to increase over coming months as companies, especially those in the retail sector, look to notify the market that activity has dampened.

But overall, we see a shallow peak-to-trough earnings decline with the Australian economy likely to hold up relatively well versus other developed market peers.

While market volatility is likely to linger, more realistic earnings expectations, alongside peak policy rates and ongoing progress in bringing inflation down, should provide a good starting point for a strong equity rally into the second half of the year.

Low risk of bank contagion

The US banking crises in early March have created some concern about potential contagion to Australian banks. However, we would argue that our banks are very different when compared to those of the US.

The US has a significant number of regional banks, and not many of them are well-capitalised, which has created problems in a rising interest rate environment that has seen intense competition for deposits. In comparison, our banks are very well-capitalised, profitable and mark to market regularly. We believe the risk of contagion is low.

In addition, if our banks are getting sold off on the back of the US banking weaknesses, then that’s actually a very good opportunity to buy the Australian banking sector at a discount, and get access to extremely attractive dividend yields.

Opportunities

Like the banking sector, other opportunities in these kinds of markets lie in those companies that are being sold off on weakening near-term outlooks. One such company we like is a2 Milk.

Its share price has underperformed on the weakness of the Daigou channel (Chinese students and tourists coming into Australia and buying the product to send home), as well as strong sales by a China label in China.

Our view is that Chinese students and tourists will return to Australia, they’re just taking a little longer than the market anticipated.

We are optimistic this company will deliver some of the best earnings growth compared to the rest of the Australian market, with attractive earnings multiples in the low-20s.

We continue to be very bullish on the China reopening thematic and A2M is well positioned within that theme, as are many Australian companies in the travel, education and resources sectors.

Another ugly duckling company we like is Xero, which has recovered somewhat from its lows. This is a high growth tech company, that is transitioning from growth at any cost to profitability, and has made very good inroads.

We expect a good result in its upcoming reporting announcement, and is the kind of company investors should look to buy at a discount in a volatile market.

Resources sector gems

The market has become very pessimistic about resources companies, but we see good buying opportunities in this sector as well.

We may be three months early, but we have found that by being the first investor in a thematic, we are often in the best position to benefit from forecast rallies.

This is another sector that will do well from the Chinese reopening that, as outlined above, may be late but is definitely gathering momentum.

Data we have analysed on credit growth and consumer spending in China certainly points to very strong economic growth over the next six months, and recently announced GDP estimates in the provinces have also been much better than expected.

We are confident that despite the current weakness, the strong China thematic will play out, and current prices offer investors a good bargain on some quality companies in this sector.

Light at the end of the tunnel

We remain positive on the Australian equity market, particularly heading into the second half of the year when corporate earnings are likely to stabilise, and markets will rebound as they focus on a bottom in economic and earnings momentum.

Investors would do well to look for good quality companies at cheaper prices in the volatility that may continue for the next few months before a better second half.

Licensed by Copyright Agency. You must not copy this work without permission.

This article was originally posted by The Australian Financial Review here.

Disclaimer: This material has been prepared by The Australian Financial Review, published on 7 May 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

We came into 2023 with a positive, non-consensus view on Australian shares.

We maintain this view, and think the outlook is not as bad as forecast by many in the market; Australia is likely to avoid the deep downgrades that are now beginning to unfold elsewhere in the world, most notably in the US.

The ASX 200, along with other global sharemarket indices, has shown a healthy uptrend since the beginning of the year.
Corporate earnings are likely to stabilise in the second half. Louie Douvis

There will, of course, be some near-term weaknesses as tighter monetary policy eventually slows activity, and we expect earnings downgrade momentum to increase over coming months as companies, especially those in the retail sector, look to notify the market that activity has dampened.

But overall, we see a shallow peak-to-trough earnings decline with the Australian economy likely to hold up relatively well versus other developed market peers.

While market volatility is likely to linger, more realistic earnings expectations, alongside peak policy rates and ongoing progress in bringing inflation down, should provide a good starting point for a strong equity rally into the second half of the year.

Low risk of bank contagion

The US banking crises in early March have created some concern about potential contagion to Australian banks. However, we would argue that our banks are very different when compared to those of the US.

The US has a significant number of regional banks, and not many of them are well-capitalised, which has created problems in a rising interest rate environment that has seen intense competition for deposits. In comparison, our banks are very well-capitalised, profitable and mark to market regularly. We believe the risk of contagion is low.

In addition, if our banks are getting sold off on the back of the US banking weaknesses, then that’s actually a very good opportunity to buy the Australian banking sector at a discount, and get access to extremely attractive dividend yields.

Opportunities

Like the banking sector, other opportunities in these kinds of markets lie in those companies that are being sold off on weakening near-term outlooks. One such company we like is a2 Milk.

Its share price has underperformed on the weakness of the Daigou channel (Chinese students and tourists coming into Australia and buying the product to send home), as well as strong sales by a China label in China.

Our view is that Chinese students and tourists will return to Australia, they’re just taking a little longer than the market anticipated.

We are optimistic this company will deliver some of the best earnings growth compared to the rest of the Australian market, with attractive earnings multiples in the low-20s.

We continue to be very bullish on the China reopening thematic and A2M is well positioned within that theme, as are many Australian companies in the travel, education and resources sectors.

Another ugly duckling company we like is Xero, which has recovered somewhat from its lows. This is a high growth tech company, that is transitioning from growth at any cost to profitability, and has made very good inroads.

We expect a good result in its upcoming reporting announcement, and is the kind of company investors should look to buy at a discount in a volatile market.

Resources sector gems

The market has become very pessimistic about resources companies, but we see good buying opportunities in this sector as well.

We may be three months early, but we have found that by being the first investor in a thematic, we are often in the best position to benefit from forecast rallies.

This is another sector that will do well from the Chinese reopening that, as outlined above, may be late but is definitely gathering momentum.

Data we have analysed on credit growth and consumer spending in China certainly points to very strong economic growth over the next six months, and recently announced GDP estimates in the provinces have also been much better than expected.

We are confident that despite the current weakness, the strong China thematic will play out, and current prices offer investors a good bargain on some quality companies in this sector.

Light at the end of the tunnel

We remain positive on the Australian equity market, particularly heading into the second half of the year when corporate earnings are likely to stabilise, and markets will rebound as they focus on a bottom in economic and earnings momentum.

Investors would do well to look for good quality companies at cheaper prices in the volatility that may continue for the next few months before a better second half.

Licensed by Copyright Agency. You must not copy this work without permission.

This article was originally posted by The Australian Financial Review here.

Disclaimer: This material has been prepared by The Australian Financial Review, published on 7 May 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on May 07, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.